Clinical Trial Update: Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether pioglitazone can prevent weight gain in adults with Type 2 diabetes; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone (Actos) (pioglitazone)

Snippet

Sponsor: Northwestern University | Conditions: Type 2 Diabetes, Obesity | Phase 3 | Status: COMPLETED